文献速递产科母胎医学

妊娠36周可溶性fms样酪氨酸激酶-1/胎盘生长因子比值与低危妊娠自然临产及产时胎儿窘迫的关联

Soluble fms-like tyrosine kinase-1/placental growth factor ratio at 36 weeks' gestation: association with spontaneous onset of labor and intrapartum fetal compromise in low-risk pregnancies.
PubMed 文献 · Am J Obstet Gynecol · 2024-08-23

该研究回顾性分析于国王学院医院35+0至36+6周常规评估的单胎妊娠孕妇资料,共23,831例自然临产者纳入分析。结果显示,可溶性fms样酪氨酸激酶-1/胎盘生长因子比值>50与更早自然临产(39.2 vs 40.0周,P<.001)及更高产时胎儿窘迫累积发生率(6.7% vs 4.7%,P<.001)相关,风险比1.424(95%CI 1.253-1.618,P<.001)。

要点

  • 36周sFlt-1/PlGF比值>50者自然临产约早1周(39.2 vs 40.0周,P<.001)。
  • 比值>50者自然临产风险比为1.424(95%CI 1.253-1.618,P<.001)。
  • 比值>50者产时胎儿窘迫累积发生率为6.7%,≤50者为4.7%(P<.001)。

核心结论

  • 36周sFlt-1/PlGF比值升高与自然临产孕周更早及产时胎儿窘迫发生率更高相关。

研究设计与样本

  • 回顾性分析前瞻性收集的数据,纳入在国王学院医院35+0至36+6周常规评估的单胎妊娠孕妇。
  • 筛查人群45,375例,其中23,831例(52.5%)自然临产并纳入分析。
  • 排除引产或临产前剖宫产的病例。
  • 采用一般线性模型、竞争风险回归和Cox回归模型分析。

主要发现

  • sFlt-1/PlGF比值>50者较≤50者分娩约早1周(39.2 vs 40.0周,P<.001)。
  • 比值>50者自然临产累积发生率显著高于≤50者(P<.001),风险比1.424(95%CI 1.253-1.618,P<.001)。
  • 产时胎儿窘迫者平均sFlt-1/PlGF比值高于无胎儿窘迫者(21.79 vs 17.67,P<.001)。
  • 比值>50者产时胎儿窘迫累积发生率为6.7%,≤50者为4.7%(P<.001)。
  • 产时胎儿窘迫病例中sFlt-1/PlGF比值>50的比例随孕周进展从35%降至0%。

临床怎么用

  • 作者认为sFlt-1/PlGF比值>50提示即将临产,平均风险增加约40%。
  • 作者认为该比值升高增加产时胎儿窘迫风险,但结局变异性提示需在多标志物模型中重新评估。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous evidence showed that placental dysfunction triggers spontaneous preterm or term births and intrapartum fetal compromise and often requires urgent delivery, thereby exposing both the fetus and the mother to significant risks. Predicting spontaneous labor onset and intrapartum fetal compromise could improve obstetrical management and outcomes, but this is currently difficult, particularly in low-risk populations. OBJECTIVE: The objective of this study was to examine whether placental dysfunction, as assessed at 36 weeks' gestation by the soluble fms-like tyrosine kinase-1 to placental growth factor ratio, is associated with the interval to spontaneous onset of labor and intrapartum fetal compromise that requires cesarean delivery in a routinely examined population. STUDY DESIGN: This was a retrospective analysis of prospectively collected data of women with singleton pregnancies who underwent routine assessment at 35+0 to 36+6 weeks' gestation at the King's College Hospital (London, England). Using a general linear model, the study examined the outcomes related to the soluble fms-like tyrosine kinase-1/placental growth factor ratio, including the time interval from testing to spontaneous onset of labor and the subsequent rate of fetal compromise that required a cesarean delivery. Patients who underwent induction of labor or prelabor cesarean deliveries were excluded from the study. Competing risks regression and Cox regression models were used to estimate the cumulative incidence and the risk of the outcomes of interest. RESULTS: In the screened population of 45,375 patients, 23,831 (52.5%) had spontaneous onset of labor and were included in the analysis. Cases with an soluble fms-like tyrosine kinase-1/placental growth factor ratio >50 delivered about 1 week earlier than those with a ratio of ≤50 (39.2 vs 40.0 weeks' gestation; P<.001). The general linear model showed that a larger soluble fms-like tyrosine kinase-1/placental growth factor ratio was associated with earlier spontaneous onset of labor (P<.001), particularly among multiparous women. The soluble fms-like tyrosine kinase-1/placental growth factor ratio was significantly associated, as expected, with cases of preeclampsia and advanced maternal age. The cumulative incidence of spontaneous onset of labor was significantly higher in cases with an soluble fms-like tyrosine kinase-1/placental growth factor ratio >50 than in those with a ratio 50 (P<.001). Cox regression showed that the risk for spontaneous onset of labor increased with an soluble fms-like tyrosine kinase-1/placental growth factor ratio >50 (hazard ratio, 1.424; 95% confidence interval, 1.253-1.618; P<.001) and, as expected, the risk was mitigated over time from when the soluble fms-like tyrosine kinase-1/placental growth factor ratio was measured to spontaneous labor onset (P<.001). Cases with intrapartum fetal compromise had a higher mean soluble fms-like tyrosine kinase-1/placental growth factor ratio than those without intrapartum fetal compromise (21.79 vs 17.67; P<.001). Qualitative addition of fetal compromise to the general linear model showed a higher soluble fms-like tyrosine kinase-1/placental growth factor ratio in cases with fetal compromise than in those without fetal compromise (P=.014). Competing risks regression showed a positive dose-response effect for fetal compromise with increasing soluble fms-like tyrosine kinase-1/placental growth factor ratios (P<.001). Above and below the optimal cutoff of 50, the quoted cumulative incidences were 6.7% and 4.7%, respectively (P<.001). The effect of the soluble fms-like tyrosine kinase-1/placental growth factor ratio remained significant even after adjusting for preeclampsia, which is a well-known major risk factor for fetal compromise. Finally, the proportion of cases with intrapartum fetal compromise who had an soluble fms-like tyrosine kinase-1/placental growth factor ratio >50 decreased from 35% to 0% with advancing gestation. CONCLUSION: This study showed that an increased soluble fms-like tyrosine kinase-1/placental growth factor ratio at 36 weeks' gestation is associated with an earlier gestational age at spontaneous onset of labor and higher rates of intrapartum fetal compromise. There are 2 major implications, namely an soluble fms-like tyrosine kinase-1/placental growth factor ratio >50 indicates imminent labor onset with about a 40% mean risk increase and immediate clinical translation for term pregnancy monitoring. In addition, an increased soluble fms-like tyrosine kinase-1/placental growth factor ratio increases the risk for intrapartum fetal compromise, although outcome variability indicates reassessment within multimarker models.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Farina A, Cavoretto PI, Syngelaki A, et al. Soluble fms-like tyrosine kinase-1/placental growth factor ratio at 36 weeks' gestation: association with spontaneous onset of labor and intrapartum fetal compromise in low-risk pregnancies. Am J Obstet Gynecol. 2024. PMID: 39181498. doi:10.1016/j.ajog.2024.08.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。